# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-25-000285
Filing Date
2025-03-06
Accepted
2025-03-06 16:24:53
Documents
93
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | tmb-20241231x10k.htm iXBRL | 10-K | 2702279
2 | EX-10.36 | tmb-20241231xex10d36.htm | EX-10.36 | 109881
3 | EX-19.1 | tmb-20241231xex19d1.htm | EX-19.1 | 56532
4 | EX-21.1 | tmb-20241231xex21d1.htm | EX-21.1 | 14317
5 | EX-23.1 | tmb-20241231xex23d1.htm | EX-23.1 | 6322
6 | EX-31 | tmb-20241231xex31.htm | EX-31 | 14572
7 | EX-32 | tmb-20241231xex32.htm | EX-32 | 7484
8 | GRAPHIC | tmb-20241231x10k001.jpg | GRAPHIC | 51376
9 | GRAPHIC | tmb-20241231x10k002.jpg | GRAPHIC | 54975
| Complete submission text file | 0001410578-25-000285.txt |  | 11461827

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | EX-101.SCH | tmb-20241231.xsd | EX-101.SCH | 76248
11 | EX-101.CAL | tmb-20241231_cal.xml | EX-101.CAL | 80502
12 | EX-101.DEF | tmb-20241231_def.xml | EX-101.DEF | 296786
13 | EX-101.LAB | tmb-20241231_lab.xml | EX-101.LAB | 647690
14 | EX-101.PRE | tmb-20241231_pre.xml | EX-101.PRE | 486804
96 | EXTRACTED XBRL INSTANCE DOCUMENT | tmb-20241231x10k_htm.xml | XML | 1850133

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12584 | Film No.: 25715632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)